On March 31, 2025, the U.S. District Court for the Eastern District of Texas ruled that the Food and Drug Administration (FDA) lacks the statutory authority to regulate laboratory-developed tests (LDTs).

The court’s judgment vacates the agency’s controversial final rule of May 6, 2024 (the “Final Rule”), regulating LDTs as medical devices, just weeks before the Final Rule’s initial implementation deadline and remands the issue back to the FDA for further consideration.

Key Takeaways

  1. Implementation of the Final Rule would have imposed major burdens on many laboratories that will now no longer apply.
  2. Manufacturers and distributors of laboratory reagents and equipment may be subject to FDA enforcement.
  3. The FDA and the Centers for Medicare & Medicaid Services have collaborated to align their roles in the regulation of LDTs, as highlighted in their joint statement.
  4. Despite recent developments, questions persist regarding whether updates or revisions to the current regulatory framework for LDTs will be issued.
  5. Any regulatory updates could have significant implications for stakeholders in the diagnostics and health care sectors, emphasizing the need for continued vigilance and compliance. Epstein Becker Green is dedicated to keeping clients informed and equipped to navigate potential changes in the regulatory landscape for LDTs.

For more information on the Final Rule, read "The LDT Final Rule Bites the Dust: Examining the Repercussions of the Federal Court’s Vacatur and What the Future May Hold."

About Thought Leaders in Health Law

The Thought Leaders in Health Law® video series tracks the latest trends in multiple areas of the health care and life sciences industries, featuring attorneys and advisors from Epstein Becker Green and EBG Advisors.

Trouble viewing this video? Please contact us at thisweek@ebglaw.com and mention whether you were at home or working within a corporate network. We'd also love to hear your suggestions for future episode topics.

SUBSCRIBE FOR EMAIL NOTIFICATIONS

THOUGHT LEADERS IN HEALTH LAW® is a registered trademark of Epstein Becker & Green, P.C.

More Like This

Back to Series
Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.